Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

BioDuro Opens Second China CRO Lab, This One in Shanghai

publication date: May 16, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
BioDuro has opened a new laboratory in Shanghai, complementing its existing facility in Beijing. BioDuro is a China pre-clinical CRO, established in 2005, that serves an international and domestic clientele. It was bought by PPD® in 2009 for $77 million. BioDuro said the new facility would allow the company to offer drug discovery services with greater efficiency and consistency through the stages of development. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...